Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-16

FDA Approved: CLORAZEPATE DIPOTASSIUM — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' original application for a generic clorazepate dipotassium product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLORAZEPATE DIPOTASSIUM (Clorazepate dipotassium)

Snippet

ORIG AP for CLORAZEPATE DIPOTASSIUM (CLORAZEPATE DIPOTASSIUM)